BB Biotech AG (BION) — Financial Flexibility Index
BB Biotech AG (BION) has a Financial Flexibility Index of -24.64x as of June 2025. Free cash flow of CHF-59.96 Million (operating CF CHF-59.96 Million minus capex CHF0.00) represents -25% of total liabilities (CHF2.43 Million). Also explore BION shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BB Biotech AG Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for BB Biotech AG across 23 annual periods. Check BB Biotech AG PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for BB Biotech AG (2003–2025)
Year-by-year free cash flow to debt coverage for BB Biotech AG. For the full company profile including market capitalisation, see BION market cap.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 44.33x | CHF309.14 Million | CHF309.14 Million | CHF6.97 Million | ▲ +1662.7% |
| 2024 | 2.51x | CHF304.56 Million | CHF304.56 Million | CHF121.11 Million | ▲ +261.7% |
| 2023 | 0.70x | CHF218.28 Million | CHF218.28 Million | CHF313.94 Million | ▲ +171.4% |
| 2022 | -0.97x | CHF-357.81 Million | CHF-357.81 Million | CHF367.25 Million | ▲ +14.6% |
| 2021 | -1.14x | CHF-404.81 Million | CHF-404.81 Million | CHF355.00 Million | ▼ -127.4% |
| 2020 | 4.17x | CHF262.45 Million | CHF262.45 Million | CHF63.00 Million | ▲ +213.1% |
| 2019 | 1.33x | CHF215.02 Million | CHF215.02 Million | CHF161.59 Million | ▲ +157.1% |
| 2018 | -2.33x | CHF-471.34 Million | CHF-471.34 Million | CHF202.33 Million | ▼ -133.6% |
| 2017 | 6.94x | CHF687.50 Million | CHF687.50 Million | CHF99.12 Million | ▲ +293.0% |
| 2016 | -3.59x | CHF-802.07 Million | CHF-802.07 Million | CHF223.22 Million | ▼ -191.1% |
| 2015 | 3.94x | CHF652.82 Million | CHF652.82 Million | CHF165.51 Million | ▼ -89.2% |
| 2014 | 36.51x | CHF1.47 Billion | CHF1.47 Billion | CHF40.27 Million | ▲ +260.5% |
| 2013 | 10.13x | CHF931.83 Million | CHF931.83 Million | CHF92.00 Million | ▲ +285.3% |
| 2012 | 2.63x | CHF367.83 Million | CHF367.83 Million | CHF139.94 Million | ▲ +132.4% |
| 2011 | 1.13x | CHF169.52 Million | CHF169.52 Million | CHF149.89 Million | ▲ +786.7% |
| 2010 | -0.16x | CHF-23.41 Million | CHF-23.41 Million | CHF142.15 Million | ▼ -100.5% |
| 2009 | 36.28x | CHF167.84 Million | CHF167.84 Million | CHF4.63 Million | ▲ +714.6% |
| 2008 | 4.45x | CHF509.39 Million | CHF509.39 Million | CHF114.37 Million | ▲ +586.5% |
| 2007 | 0.65x | CHF201.02 Million | CHF201.02 Million | CHF309.83 Million | ▲ +1085.6% |
| 2006 | -0.07x | CHF-19.80 Million | CHF-19.80 Million | CHF300.86 Million | ▼ -134.0% |
| 2005 | -0.03x | CHF-6.14 Million | CHF-6.14 Million | CHF218.35 Million | ▼ -100.1% |
| 2004 | 29.92x | CHF107.32 Million | CHF107.32 Million | CHF3.59 Million | ▲ +855.9% |
| 2003 | -3.96x | CHF-172.22 Million | CHF-172.22 Million | CHF43.51 Million | — |